Skip to main content
Premium Trial:

Request an Annual Quote

German Start Up to Automate Novel Form of Cloning

NEW YORK, April 9 - German genomics-tool start up Sloning Biotechnology today said it has partnered with neighboring liquid-handling company Hamilton Bonaduz to commercialize its Slonomat gene synthesis robot.

 

The collaboration means that Sloning's sloning technology, which allows for the "industrial synthesis" of DNA molecules, can be fully automated.

According to Sloning, sloning can help researchers produce "any gene or large DNA molecule ... within a couple of days." The Slonomat platform, meanwhile, has the capacity of several hundred genes per year. Sloning technology differs from traditional cloning in that it "works without the need for insert restriction sites," the company said. "It allows parallel synthesis of several gene variants and shows inherent error correction."

 

The privately held company, founded in December 2001, is based just outside Munich.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.